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Slowed myocardial conduction velocity (θ) is associated with an increased risk of re-entrant
excitation, predisposing to cardiac arrhythmia. θ is determined by the ion channel and
physical properties of cardiac myocytes and by their interconnections. Thus, θ is closely
related to the maximum rate of action potential (AP) depolarization [(dV /dt)max], as
determined by the fast Na+ current (INa); the axial resistance (ra) to local circuit current
flow between cells; their membrane capacitances (cm); and to the geometrical relationship
between successive myocytes within cardiac tissue. These determinants are altered by
a wide range of pathophysiological conditions. Firstly, INa is reduced by the impaired
Na+ channel function that arises clinically during heart failure, ischemia, tachycardia, and
following treatment with class I antiarrhythmic drugs. Such reductions also arise as a
consequence of mutations in SCN5A such as those occurring in Lenègre disease, Brugada
syndrome (BrS), sick sinus syndrome, and atrial fibrillation (AF). Secondly, ra, may be
increased due to gap junction decoupling following ischemia, ventricular hypertrophy, and
heart failure, or as a result of mutations in CJA5 found in idiopathic AF and atrial standstill.
Finally, either ra or cm could potentially be altered by fibrotic change through the resultant
decoupling of myocyte–myocyte connections and coupling of myocytes with fibroblasts.
Such changes are observed in myocardial infarction and cardiomyopathy or following
mutations in MHC403 and SCN5A resulting in hypertrophic cardiomyopathy (HCM) or
Lenègre disease, respectively. This review defines and quantifies the determinants of
θ and summarizes experimental evidence that links changes in these determinants
with reduced myocardial θ and arrhythmogenesis. It thereby identifies the diverse
pathophysiological conditions in which abnormal θ may contribute to arrhythmia.
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INTRODUCTION
Impaired myocardial action potential (AP) conduction can pre-
dispose to arrhythmogenesis through the formation of slow con-
ducting re-entry circuits. Re-entry was first defined by Mines in
the early twentieth century as a persisting electrical impulse that
reactivates an area of previously activated myocardial tissue that is
no longer refractory, resulting in a circus movement of activation
(Mines, 1914). Subsequent studies suggest that sustained arrhyth-
mia requires an ectopic AP triggering event to occur within such a
substrate capable of generating self-sustaining re-entry processes
(Mandapati et al., 2000; Zou et al., 2005). Thus, a triggered electri-
cal impulse must enter a perpetuating electrical circuit containing
a unidirectional conduction block along one of its two pathways.
Such re-entry within the circuit is more likely to occur following
reductions in conduction velocity (θ) and/or the effective refrac-
tory period (ERP). As shown in Figure 1, this could result in a
reduction in the wavelength of excitation (λ), given by the prod-
uct of θ and ERP, to values smaller than the dimensions of the
available circuits (Mines, 1914; Wiener and Rosenblueth, 1946;
Wakili et al., 2011). Alternatively if the site of slowed conduction
is such that it prevents propagation of the triggered AP into the
circuit, it may discourage re-entry.
This review describes the generation and propagation of the
cardiac AP and defines the determinants of θ. It summarizes
experimental evidence that links changes in these determinants
with reduced myocardial θ and arrhythmogenesis, thereby iden-
tifying the diverse pathophysiological conditions in which abnor-
mal θ may contribute to arrhythmogenesis.
THE GENERATION OF THE ACTION POTENTIAL
Cardiac APs are time-dependent voltage waveforms that prop-
agate along excitable tissues. AP generation arises from specific
changes in membrane permeability resulting in a sequence of
selective ion fluxes through their contained ion channels down
their electrochemical gradients. Cardiac AP waveforms have been
divided into five phases. The AP is initiated by transmem-
brane potential depolarization beyond an “activation thresh-
old” at which inward currents exceed outward currents. This
results in a Na+ influx through voltage-sensitive Na+ chan-
nels that show a regenerative increase to result in large depo-
larizing Na+ currents (INa) (of order 400μA μF−1). These
generate the initial rapid (∼400V s−1) phase 0 upstroke of
the AP. The maximum rate of AP depolarization [(dV/dt)max]
in an isolated cell is thus directly proportional to the total
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FIGURE 1 | The relationships between θ and re-entrant arrhythmia.
A diagram illustrating a typical re-entry circuit, consisting of a pathway of
slow conducting myocardium [A(i) path 1, light gray] passing through
non-conducting myocardium (dark gray), bordered by a second pathway of
normal myocardium [A(i) path 2, white]. (A) An electrical impulse (blue arrow)
originating from the SAN, (i) propagates along path 2 (white) and path 1 (light
gray) pathways. As the impulse conducts, the myocardium becomes
refractory (yellow in path 2 or orange in path 1) (ii) The impulse that travels
along path 2 reaches the end of the circuit resulting in a normal AP. The
impulse that conducts along 1 cannot exit the circuit as it collides with the
refractory tissue of path 2. (B) An abnormal impulse originating from an
ectopic focus is triggered immediately following the sinus impulse (i). It
cannot conduct down path 1 which remains refractory; it therefore conducts
along path 2. (ii) When the impulse reaches the distal end of path 2 it splits,
conducting retrogradely along path 1 and orthogradely along path 2. (C) The
impulse conducting retrogradely along path 1 then activates the beginning of
path 2 (i) without the need of any further stimuli, thereby creating a
self-perpetuating re-entrant rhythm (ii). Such re-entry is more likely to occur
following reductions in conduction velocity (θ) and/or the effective refractory
period (ERP ) that reduce the wavelength of excitation (λ), given by the
product of the θ and ERP, to values smaller than the dimensions of the
available circuits.
ionic current across the cell membrane (Ii) (Hodgkin and Katz,
1949).
As INa is the major transmembrane current in phase 0,
(dV/dt)max is therefore often used as an index of INa. Having
reached its peak amplitude, INa quickly inactivates in less than
1ms, and requires an ERP to elapse before any further exci-
tation. The succeeding brief rapid repolarization (phase 1) is
additionally driven by the rapid activation and inactivation of K+
channels carrying the fast and slow transient outward currents,
Ito,f, and Ito,s, respectively. This is then followed by a plateau phase
(phase 2) during which inward Ca2+ currents (ICaL) through
the L-type Ca2+ channels are balanced by INCX, resulting from
3Na+/Ca2+ exchanger (NCX) activity, the ATP-activated K+ cur-
rent (IKATP), and progressively activating Iks and Ikr,: the slow
and rapid components of the delayed outward rectifying K+ cur-
rent. Finally the outward currents, particularly IKr, terminate the
AP during phase 3 rapid repolarization. The resting membrane
potential during the final, phase 4, electrical diastole, is primarily
set by inward-rectifier currents (IK1), fixing the resting membrane
potential close to the K+ equilibrium potential of about −80
to −90mV.
The resting membrane potential persists until the next
appropriately-initiated AP unless there is ectopic activity. Ectopic
APs can be triggered by two types of afterdepolarization phe-
nomena: early afterdepolarizations (EADs), or delayed afterde-
polarizations (DADs). EADs are repolarization abnormalities
characterized by oscillations in the membrane potential during
phase 2 or 3 of the AP. They result from abnormalities in INa
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inactivation, reductions in the outward K+ currents (IK1, IKs,
and Ito), or increases in inward ICaL, that then allow reactiva-
tion of INa, a persistent late Na+ current, INaL, or both, thereby
compromising the net outward current required to repolarize the
myocyte. In contrast, DADs are formed during phase 3 or 4 of
the AP when Ca2+ released by an abnormal diastolic sarcoplas-
mic reticulum (SR) Ca2+ discharge is exchanged for extracellular
Na+ via the NCX. Since NCX removes only 1 Ca2+ for every 3
Na+ entering, it causes a net inward current and depolarization
of the cell. If the resulting afterdepolarization is large enough to
displace the membrane voltage beyond the activation threshold,
an extrasystole is induced.
ACTION POTENTIAL PROPAGATION AND ITS
DETERMINANTS
The magnitude of INa also plays a major role in the subsequent
propagation of the cardiac impulse to its neighboring cells. In a
simple model of AP propagation, an axial current flows along a
linear cellular structure, or cable, from one depolarized myocyte
to its quiescent neighbor via intercellular channels known as gap
junctions (Rohr, 2004). If this axial current is sufficient to depo-
larize the neighboring cell beyond its activation threshold, voltage
sensitive Na+ channels will create transmembrane currents capa-
ble of propagating the AP. The axial resistance (ra) to such local
circuit currents arises from the resistances of the cytosol and the
gap junctions between adjacent cells. Thus, in addition to Na+
channels, gap junctions play a critical role in AP propagation and
influence its velocity.
The determinants of θ can be identified using the nonlinear
cable equation (Plonsey and Barr, 2007; Keener and Sneyd, 2009).
This incorporates circuit elements each made up of a capacitance
of unit fiber length, cm, (μF cm−1) in parallel with both a lin-
ear membrane resistance of unit fiber length rm (k cm) and
nonlinear conductance elements responsible for individual ion
channel properties. Together these generate a total current ii in
unit fiber length, x, as a function of time, t. Successive circuit ele-
ments are connected by elements reflecting cytoplasmic and gap
junction resistances intervening between cells. These give rise to
the effective intracellular ra of unit fiber length, ra, In classical
cable theory, ra is assumed constant. The membrane potential,
V, across any given capacitative element depends on the charging
of its unit length by currents traversing the local membrane con-
ductance elements, ii, as well as the axial current flow, ia, arising
from neighboring regions along the length, x, of the element in
question. Thus,
1
ra
(
d2V
dx2
)
= cm
(
dV
dt
)
+ ii
At constant conduction velocity θ = dx/dt, and so:
1
θ2ra
(
d2V
dt2
)
= cm
(
dV
dt
)
+ ii
This simplest version of the cable equation clearly identifies the
key determinants of θ as ra, cm, and ii. However, several of its
terms are interdependent, as will be discussed below, precluding
its analytic solution. Furthermore, it is a stiff equation, requiring
a good estimate of θ to be made before numerical solutions may
be obtained (Jack et al., 1983) However, it is possible to derive
simple relationships between θ and the parameters identified by
this equation using a computer model of electrical conduction in
a muscle fiber (Fraser et al., 2011). Although this model simulates
skeletal rather than cardiac muscle, the insights that it provides
into cable properties have general validity for any system in which
fast sodium currents dominate the AP upstroke.
Thus, Figure 2 demonstrates the empirical influences of ra,
cm, and ii upon θ and AP waveform in a computer model of
AP propagation. It confirms that ii is principally determined
by INa during the AP upstroke, and demonstrates that iNa(max)
α log[PNa(max)] (R2 = 0.9965), where PNa(max) is the maximum
permeability of the fast Na+ channels. Several important relation-
ships then emerge that allow measurements of the AP waveform
to be used to investigate relative changes in iNa(max) and cm.
First, (Figure 2A) ra does not influence the AP waveform
[Figure 2A(i)] and thus does not influence dV/dt [Figure 2A(ii)]
or d2V/dt2 (not shown). Consequently, θ2 α 1/ra (R2 = 1.0000)
[Figure 2A(iii)] as predicted from the cable equation. This simple
relationship emerges because ra influences only the AP waveform
as a function of distance, not as a function of time. The effect is
similar if ra is unevenly distributed, as in cardiac myocytes con-
nected by gap junctions (data not shown). Simulations show that,
although uneven distribution of ra produces small increases in
AP amplitude and (dV/dt)max immediately before high resistance
areas and small decreases in these parameters immediately after,
θ and distance-averaged values of AP amplitude and (dV/dt)max
are influenced as for evenly-distributed increases in ra.
Second, (Figure 2B) increases in cm influence the AP
waveform [Figure 2B(i)], slowing the voltage excursions
[Figure 2B(ii)] and producing a reduction in θ. Interestingly, θ2
α 1/cm (R2 = 0.9996) [Figure 2B(iii)], as it appears in the cable
equation, despite the influence of cm on dV/dt and d2V/dt2 (not
shown). These relationships have good empirical approxima-
tions: (dV/dt)max α log(cm) (R2 = 0.9977) and (d2V/dt2)max α
1/cm (R2 = 1.0000).
Finally, (Figure 2C), the relationship between iNa(max) and θ
is difficult to derive from the cable equation because of the very
large influence of iNa(max) upon AP waveform [Figure 2C(i)]
and (dV/dt)max [Figure 2C(ii)] and d2V/dt2 (not shown).
Nevertheless, the resultant empirical relationship for the range
of values depicted in Figure 2C is straightforward: θ α iNa(max)
(R2 = 1.0000) [Figure 2C(iii)]. The AP waveform is influenced
by iNa(max) as follows: (dV/dt)max α
√
iNa(max)
3 (R2 = 0.9996);
and (d2V/dt2)max α iNa(max)
3 (R2 = 0.9996).
The cable equation can be extended from geometrically well-
defined cylinders to cardiac tissue consisting of a continuous net-
work of electrically-coupled cells. In doing so the analysis above
becomes extended to one that determines conduction velocity
resulting from the match between current and load (Kucera et al.,
1998). Such an approach has been used to describe the macro-
scopic passive electrical properties of cardiac muscle (Weidmann,
1970; Kléber and Riegger, 1987), the relationship between dV/dt
and macroscopic (>1mm) propagation (Buchanan et al., 1985)
and changes in cell to cell coupling.
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FIGURE 2 | Quantification of the determination of θ in a computer
model. The cable equation identifies ra, cm, and ii as the determinants of θ,
but does not clearly demonstrate the magnitudes of their influences.
Computer modeling of a skeletal muscle fiber (Fraser et al., 2011) shows the
influence of ra (panel A), cm (panel B), and iNa(max) (panel C) on AP waveform
(i), dV/dt (ii), and θ (iii). In panels i and ii, three representative APs are shown,
each stimulated at 1s and recorded 2.5mm further along the cable, such that
increased times to the AP peaks denote slowed conduction. In panel iii, the
velocities of these APs are labeled 1, 2, and 3. It will be noted that ra
influences θ but not AP waveform, whereas cm and iNa(max) each influence
AP waveform and θ. Note that in panel C(iii), θ is plotted against both iNa(max)
(upper scale, squares) and PNa(max) (lower scale, triangles). The simple
quantitative relationships between these parameters that emerge from this
analysis are given in the text.
As summarized in Figure 3, experimental studies have sug-
gested a range of mechanisms through which changes in AP
propagation leading to increased arrhythmic tendency can take
place. They have been attributed to alterations in Na+ channel
and gap junction function, as well as to the consequences of
fibrotic change. These could potentially alter the major determi-
nants of θ: transmembrane current (ii), cell to cell coupling (ra),
and cell capacitance (cm), outlined in the quantitative analysis
above.
THE Na+ CHANNEL AND ITS RELATIONSHIP TO INa
Na+ channels are transmembrane proteins responsible for a
rapid, voltage-dependent, influx of Na+ ions. They are located
within the surface and transverse (t)-tubular membranes (Cohen,
1996) mainly concentrating in the perinexus region near gap
junctions (Lin et al., 2011; Rhett et al., 2012). Na+ channels
consist of a principal α-subunit composed of four homologous
domains each containing six, S1–S6, transmembrane segments.
The function of the α-subunit is modulated by one or two
associated ancillary β-subunits (Bezzina, 2001).
Several, Nav1.1, Nav1.3, Nav1.5, Nav1.6, α-subunits, are
known to be expressed in the mammalian heart. Of these, Nav1.5,
encoded by the SCN5A gene is the most abundant. It is a large 260
KDa glycosylated protein that forms the pore component of the
channel and has very high selective permeability for Na+ (perme-
ability ratio: Na+:K+ = 100.1) (Gellens et al., 1992; Wang et al.,
1996). Na+ influx and the resulting current flow through the open
Na+ channel (INa) are responsible for the initial rapid (phase 0)
AP depolarization and drives its propagation. It is consequently a
key determinant of θ.
ABNORMALITIES IN Na+ CHANNEL FUNCTION
Abnormalities in conduction can arise from functional muta-
tions in SCN5A that alter INa [Figure 3A(i)]. Of these the
SCN5a-1795insD mutation is associated with an overlap syn-
drome with features of bradycardia, impaired conduction, LQT3,
and Brugada syndrome (BrS) (Bezzina et al., 1999). Whilst mice
homozygous for the mutation die in utero, the heterozygous
Scn5a1798insD/+ mouse shows sinus node dysfunction, conduc-
tion slowing, and QT prolongation replicating the phenotype in
humans (Remme et al., 2006).
Acquired abnormalities can also lead to changes in Na+
channel function. Abnormalities in AP depolarization
were first described by Gelband and Bassett who recorded
decreased values of (dV/dt)max and depolarized resting
membrane potentials in experimental models of heart fail-
ure (Gelband and Bassett, 1973). Subsequent studies have
also associated heart failure with reductions in peak INa
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FIGURE 3 | Physiological influences on the determinants of θ.
Three diagrams illustrating the mechanisms by which (a) membrane
excitability, (b) cell coupling and (c) fibrotic change influence current.
Transmembrane current (dark blue arrow) enters through open Nav1.5
(green rectangle) and intercellular current (light blue arrow) passes
through open Cxs (green ladder). (A) Abnormal membrane excitability
results from reductions in either (i) Nav1.5 function through increases
in extracellular [K+] and pH and by increases in [Ca2+]i and
phosphorylation, or (ii) Nav1.5 expression by mutations in SCN5A
(Brugada syndrome) and through Ca2+ mediated down regulation of
the channel. (B) Abnormal cell coupling results from reductions in
either (i) Cx function through increases in [Ca2+]i and dephospho-
rylation or (ii) Cx expression by mutations in either CJA1 or CJA5
(idiopathic AF). (C) Abnormal fibrosis produces either (i) increased
myocyte-myocyte decoupling, resulting in increased ra,. or (ii)
Cx-mediated myocyte-fibroblast coupling, resulting in increased cm.
(Kuryshev et al., 1999; Ufret-Vincenty et al., 2001) through a
number of mechanisms including reduced Nav1.5 glycosylation
(Ufret-Vincenty et al., 2001). Pathophysiological reductions in
Na+ channel availability have been additionally described during
the acute phase of ischemia (Downar et al., 1977; Janse et al.,
1986; Kleber et al., 1986; Kabell, 1989), tachycardia (Veenstra
et al., 1987; Gaspo et al., 1997) and following treatment with class
I anti-arrhythmic drugs (Sheldon et al., 1989).
Acute ischemia is pro-arrhythmogenic due to changes in
intracellular and extracellular ionic concentrations, leading to
reduced AP amplitudes, upstroke velocities (Downar et al., 1977;
Janse et al., 1986) and conduction delays (Kleber et al., 1986;
Kabell, 1989). Ischemic extracellular changes including: increases
in [K+], decreases in pH, and hypoxia have been associated with
modulation of Na+ channel function (Corr and Yamada, 1995).
Microelectrode studies in hypoxic guinea pig papillary muscle
demonstrated a decrease in (dV/dt)max and depolarization of the
resting membrane potential that was accentuated by increases
in [K+] (Kodama et al., 1984). Subsequent studies in canine
Purkinje fibers similarly showed a 8% decrease in θ in raised [K+]
and a 4% decrease in θ following acidosis (Veenstra et al., 1987).
In addition to the extracellular effects, increases in intra-
cellular cyclic adenosine monophosphate (cAMP) and cytoso-
lic Ca2+ concentrations [(Ca2+)i] have also been reported in
acute ischemia. Stimulation of β-adrenergic receptors is thought
to produce adenylate cyclase-mediated increases in intracellular
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cAMP, leading to phosphokinase A (PKA) activation (Bers, 2002).
Modulation of Nav1.5 by PKA occurs via phosphorylation at ser-
ine 525 and 528 within the DI–DII linker (Murphy et al., 1996).
Following PKA activation, Nav1.5 redistributes to the plasma
membrane of HEK293 cells (Hallaq et al., 2006). Thismay explain
the increases in INa reported following PKA activation with dibu-
tyryl cAMP in rabbit and canine myocytes (Matsuda et al., 1992;
Baba et al., 2004).
However, further experimental studies variously show that
treatment with isoproterenol either increases (Matsuda et al.,
1992) or decreases (Ono et al., 1989; Schubert et al., 1990) INa.
Furthermore, when rabbit myocytes were treated with both a
PKA inhibitor and isoproterenol, INa remained elevated suggest-
ing that β-adrenergic stimulation produces an additional, PKA-
independent modulation of the Na+ channel. Myocytes treated
with a GTP analog and stimulatory G protein subunit showed
increased INa implicating involvement of a G protein regulatory
pathway (Matsuda et al., 1992).
In contrast to PKA activation, Ca2+-dependent activation of
the protein phosphatase calcineurin has also been shown to
strongly reduce INa, This has been variously attributed to acti-
vation of protein kinase-C (PKC) or modulation of Na+ channel
trafficking (Abriel, 2007). PKC also directly modulates Nav1.5 by
phosphorylation at serine 1505 in the DIII–DIV inactivation gate,
significantly reducing INa (Qu et al., 1996).
Changes in intracellular Ca2+ may also exert direct regula-
tory effects on the Na+ channel. Indeed the C-terminal region
of Na+ channel constructs contain two Ca2+-sensitive regions:
a calmodulin binding, IQ, domain, and a Ca2+ binding, EF-
hand, motif (Wingo et al., 2004; Chagot et al., 2009). Thus,
increases in CaMKII activity have been variously reported to
increase (Aiba et al., 2010) or decrease (Wagner et al., 2006) peak
INa. Alternatively, intracellular Ca2+ has been shown to directly
inhibit INa without affecting channel gating through a perme-
ation block. Indeed, reductions in INa density and (dV/dt)max
have been reported following increases in [Ca2+]i brought about
by changing the Ca2+ concentration in the pipette solution in
patch-clamped WT myocytes (Casini et al., 2009). Furthermore,
reductions in (dV/dt)max, θ and increased incidences of arrhyth-
mia have been shown in both homozygous gain of function
RyR2-P2328S (RyR2S/S) and caffeine-treated WT hearts that
have abnormal diastolic SR Ca2+ release (King et al., 2013b).
Both immunohistochemical and biophysical studies subsequently
attributed these abnormalities to the effects of Ca2+ homeostasis
on INa function (King et al., 2013a).
Finally, treatment with class I anti-arrhythmic drugs mod-
ulates Na+ channel function. Thus, lidocaine, mexiletine,
tocainide, and aprindine have been shown to block Na+ chan-
nels in the inactivated state whilst quinidine and disopyramide
block the open channel (Kodama et al., 1986; Sheldon et al.,
1989). Furthermore, lidocaine has been associated with impaired
conduction and the induction of ventricular tachyarrythmias in
experimental models (Anderson et al., 1990).
ABNORMALITIES IN Na+ CHANNEL EXPRESSION
Abnormalities in AP depolarization could also arise from an alter-
ation in Nav1.5 expression [Figure 3A(ii)]. Knockout mutations
in the SCN5A gene decrease INa and are associated with car-
diac conduction diseases including Lenègre disease (Schott et al.,
1999), BrS (Gussak et al., 1999), sick sinus syndrome (Benson
et al., 2003) and atrial fibrillation (AF) (Laitinen-Forsblom et al.,
2006; Ellinor et al., 2008).
Of these, BrS is associated with a high incidence of ven-
tricular tachyarrhythmias and sudden cardiac death (Gussak
et al., 1999). Although the exact pathophysiological mechanism
is not yet known (Hoogendijk et al., 2010), mutations in 17
genes have been associated with BrS of which SCN5A muta-
tions account for a significant proportion (Tan et al., 2001).
Furthermore, BrS patients with Na+ channel mutations show
significantly longer conduction intervals than those without
SCN5A mutations (Smits et al., 2002). In addition, class I anti-
arrhythmic drugs have been used to unmask the BrS ECG
pattern by exacerbating pre-existing conduction abnormalities
(Gasparini et al., 2003).
Conduction alterations in BrS have been studied using a
murine model with knock-out mutations in Scn5a (Papadatos
et al., 2002). The homozygous embryos die in utero with
severe defects in ventricular morphogenesis. Heterozygous mice
(Scn5a+/−) haploinsufficient for Nav1.5 show normal survival
with several cardiac conduction defects including decreased atrial,
ventricular and atrioventricular conduction and increased sus-
ceptibility to pacing-induced ventricular arrhythmias (Papadatos
et al., 2002).
The expression of Nav1.5 has also been shown to be regulated
by changes in intracellular ion concentrations, including Ca2+.
Thus, Nav1.5 mRNA and Nav1.5 protein expression increased
following treatment with the Ca2+ channel blocker, verapamil,
and decreased following treatment with the Ca2+ ionophore cal-
cimycin in rat cardiomyocytes (Offord and Catterall, 1989; Taouis
et al., 1991; Duff et al., 1992). Similarly, Na+ current densi-
ties increased following elevations of [Ca2+]i brought about by
increased extracellular [Ca2+]. It decreased following reductions
of [Ca2+]i produced by BAPTA-AM in patch-clamped cultured
neonatal rat myocytes (Chiamvimonvat et al., 1995).
Such changes in the expression of Na+ channels have been
reported in experimental models of atrial tachycardia that are
associated with increased [Ca2+]i (Sun et al., 2001). Thus, atrial
tachypacing decreased Nav1.5 mRNA, INa, and θ over several
weeks in canine models (Gaspo et al., 1997; Yue et al., 1999). In
contrast, the development of AF does not further reduce atrial INa
(Yagi et al., 2002) or Nav1.5 mRNA (van der Velden et al., 2000)
in canine and goat models, respectively.
GAP JUNCTIONS AND THEIR RELATIONSHIP TO ra
Gap junctions are non-selective membrane channels that form
low resistance cell-to-cell connections that permit intercellu-
lar currents, as well as the transfer of ions, amino acids, and
nucleotides. Their distribution within the cell membrane is
tissue-specific and helps determine themagnitude and anisotropy
of conduction. In general, cardiac cells express gap junctions
near Na+ channels and at higher densities toward the ends of
cells rather than their lateral margins, resulting in lower ra and
hence faster conduction in the longitudinal direction (Kumar and
Gilula, 1996).
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Gap junction channels are composed of a family of pro-
teins known as connexins (Cx). Adjacent cells each contribute a
hemichannel, made up of 6 Cxs, to the junction. There are 15
known Cxs defined by their molecular weight, each with different
channel properties and gating mechanisms. Four main variants,
Cxs 30.2, 40, 43, and 45, have been described in mammalian
cardiac tissue (Davis et al., 1994). The type and distribution
of these Cxs determines the properties of passive conduction
throughout the heart. Cx43 is the most abundant and is expressed
throughout the ventricular and atrial myocardium (Beyer et al.,
1987), whilst Cx40 is limited to atrial tissue and the His Purkinje
system (Gourdie et al., 1993a,b). Cx30.2 is only found in the
atrioventricular node (AVN) (Kreuzberg et al., 2006) and Cx45
is variously reported to be expressed in the specialized con-
ducting system (Coppen et al., 1998, 2001). Cx43 has a mod-
erate conductance of ∼110 pS and compared to other cardiac
Cx is relatively insensitive to changes in transjunctional volt-
age (Moreno et al., 1994; Veenstra, 1996). Cx40 conductances
are similar to Cx43, ∼160 pS, but they have higher sensitiv-
ities to transjunctional voltage (Beblo et al., 1995; Bukauskas
et al., 1995). In contrast, Cx45 has a much lower conduc-
tance at ∼30 ps and is extremely sensitive to transjunctional
voltage (Veenstra et al., 1994; Veenstra, 1996). These conduc-
tances are heavily regulated in healthy and pathophysiological
myocardium. The resistance of gap junctions makes up approx-
imately half of the longitudinal resistance in rat atria (Fry et al.,
2012). Thus, the conductance of Cxs and therefore gap junc-
tions help determine the magnitude of ra and are an important
determinant of θ.
ABNORMALITIES IN GAP JUNCTION FUNCTION
Mutations in the genes encoding Cxs can change gap junction
function [Figure 3B(i)] and thereby reduce cell to cell cou-
pling. Loss-of-function somatic mutations of the CJA5 gene that
expresses Cx40 have been shown to result in idiopathic AF
(Firouzi et al., 2004) and when combined with a SCN5A muta-
tion, atrial standstill (Groenewegen, 2002). Heterozygous somatic
missense mutations and polymorphisms within the gene’s reg-
ulatory region have also been linked to conduction delays and
AF (Gollob et al., 2006; Hauer et al., 2006). Other mutations of
the Cx43 gene, such as GJA1, which affects phosphorylation sites,
have been associated with cardiac structural abnormalities (Britz-
Cunningham et al., 1995; Dasgupta et al., 2001) but without
reported conduction abnormalities.
Acquired functional modifications of Cx [Figure 3B(i)] have
been shown to arise during both heart failure and myocardial
ischemia. Heart failure is associated with increased c-Src tyrosine-
mediated tyrosine phosphorylation of Cx43 leading to decreased
conductance (Toyofuku et al., 1999), conduction abnormalities
and arrhythmia (Laurita et al., 2003).
During ischemia there are pathological decreases in the con-
ductance of gap junctions following increases in [Ca2+]i (Smith
et al., 1995; De Groot et al., 2001), intracellular acidification
(Yan and Kléber, 1992) and through changes in catecholamine-
induced increases in cellular cAMP, which in turn modulate levels
of phosphorylation. Acute increases in [Ca2+]i occur in ischemic
rabbit models (Dekker et al., 1996) and are associated with gap
junctional uncoupling (De Mello, 1975; Smith et al., 1995) and
decreased conductance (Kirchhoff et al., 1998; Gutstein et al.,
2001). Such changes result in conduction slowing and conduc-
tion block (Dekker et al., 1996) that is exacerbated by increases
in intracellular pH (Kleber et al., 1986). Myocardial ischemia
also causes Cx43 to rapidly dephosphorylate (Huang et al., 1999;
Beardslee et al., 2000) leading to its lateralization, transfer from
the intercalated disks to intracellular pools and electrical uncou-
pling (Smith et al., 1991; Matsushita et al., 1999; Beardslee et al.,
2000; Lampe et al., 2000). Dephosphorylation of Cxs may also be
involved in lateralization of gap junctions resulting in conduction
abnormalities in AF (Dobrev et al., 2012). However, other studies
have reported that protein kinase C-dependent phosphorylation
of Cx43 at serine 368 is associated with decreased gap junctional
communication (Lampe et al., 2000) and conductance (Moreno
et al., 1994; Kwak et al., 1995).
ABNORMALITIES IN CONNEXIN EXPRESSION
Abnormalities in AP propagation also arise from changes in the
total number of Cxs [Figure 3B(ii)]. Such abnormalities have
been extensively modeled experimentally by using genetically
modified mice with altered Cx 40, 43, and 45 expression.
Cx45 knockout mice (Kumai et al., 2000) show normal con-
traction with atrioventricular conduction block and die in utero
at day 10, consistent with studies showing Cx45 is uniquely
expressed in the atrioventricular canal (Coppen et al., 1999,
2001). The homozygous Cx40 knockout mouse model shows
slowed conduction and a partial atrioventricular block (Leaf
et al., 2008); however arrhythmia was only observed in one
study (Kirchhoff et al., 1998). The homozygote Cx43 knock-
out mouse (Cx43−/−) dies from neonatal pulmonary outflow
obstruction (Reaume et al., 1995) but electrocardiography and
optical mapping have been used successfully to measure θ in
mice haploid insufficient for Cx43 (Cx43+/−). The first of these
studies suggested slowed conduction (Guerrero et al., 1997) but
later work contradicted these findings, showing no significant
change in θ (Kirchhoff et al., 2000; Thomas et al., 2003). However,
ischemic Cx43+/− hearts have shown conduction abnormalities
and higher incidences of spontaneous ventricular arrhythmias
compared to WT (Lerner et al., 2000).
A cardiac-restricted homozygote knockout of Cx43 model was
used to prevent the neonatal lethal structural defects in Cx43−/−.
Such mice have a 90% reduction in Cx43 with normal heart
structure and contractile function. Epicardial optical mapping
showed that both longitudinal and transverse ventricular θ was
reduced by 40–50%. In addition, Cx43 conditional knockout
mice had high incidences of spontaneous ventricular arrhyth-
mias and sudden cardiac death (Gutstein et al., 2001). These latter
findings were supported by recent modeling suggesting that in
non-ischemic conditions a 90% reduction in gap junctions is
required to decrease θ by 50% (Jongsma andWilders, 2000; Spach
et al., 2000).
Interestingly, recent studies have proposed an additional, non-
canonical method of cardiac conduction whereby the intercel-
lular transfer of charge does not only occur by the passive flow
of current through gap junctions. These studies suggest a role
for extracellular space in modulating θ (Veeraraghavan et al.,
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2012) and that connexins actively augment current propaga-
tion by the accumulation of functional sodium channels at the
perinexus of the intercalated disc and by the maintenance of nar-
row intercellular distances (Agullo-Pascual and Delmar, 2012;
Rhett et al., 2013). Such a mechanism is supported by exper-
imental evidence in cardiac restricted Cx43+/− knockout mice
that associates reduced Cx43 expression with reduced Nav1.5
expression and INa (Jansen et al., 2012). These findings high-
light one of the limitations of using simple cable theory and
help explain why decreases in connexin expression that are clas-
sically thought to increase ra do not result in proportional
decreases in θ.
Acquired changes in Cx expression have also been associ-
ated with a number of cardiac conditions including ventricular
hypertrophy, heart failure and AF. During the early stages of ven-
tricular hypertrophy there were increases in Cx expression and
myocyte coupling. Thus, neonatal rat ventricular myocytes cul-
tured in cAMP (Darrow et al., 1996) or angiotensin II (Dodge
et al., 1998), both mediators of hypertrophy, showed increases
in Cx43 expression and θ. More recent studies have shown a
100% increase in Cx43 expression and resulting θ in neonatal
ventricular myocytes cultured with a mechanical load (Zhuang
et al., 2000). θ typically increases in the acute phases of hypertro-
phy due to both increases in Cx43 expression and cell size that
decrease intercellular and longitudinal resistance, respectively
(Wiegerinck et al., 2006). Over prolonged periods of hypertro-
phy θ starts to decrease, as seen in chronic arrhythmic conditions
(Cooklin et al., 1997) where Cx43 shows 25–50% downregula-
tion (Kaprielian et al., 1998). The expression of Cx43 is down-
regulated in experimental (Akar et al., 2004; Ai and Pogwizd,
2005) and clinical (Dupont et al., 2001; Kostin et al., 2004) studies
of heart failure through recruitment of mitogen-activated pro-
tein kinase C-Jun NH2- terminal kinase (Petrich et al., 2002).
Clinical heart failure studies showed Cx45 (Yamada et al., 2003)
and Cx40 (Dupont et al., 2001) are up-regulated, possibly as a
compensatory mechanism.
There are inconsistent clinical and experimental reports
regarding changes in Cx expression during atrial tachyarrhyth-
mias such as AF. Thus, experimental studies show up regulation
of Cx43 in an atrial tachypaced canine model (Elvan et al., 1996;
Sakabe et al., 2004), increased heterogeneity of Cx40 expression
in tachypaced goat models with no changes in overall Cx expres-
sion (van der Velden et al., 1998). Whilst clinical studies support
experimental findings of increased Cx expression on lateral cell
surfaces (Smith et al., 1991; Polontchouk et al., 2001; Kostin
et al., 2002) and increased heterogeneity (Dupont et al., 2001;
Kostin et al., 2004) there is no consensus on changes in overall
Cx expression. Studies show both increases (Dupont et al., 2001;
Polontchouk et al., 2001) and decreases (Kostin et al., 2002; Nao
et al., 2003) in Cx40 and Cx43 expression. However, conduction
abnormalities are consistently described in experimental (Gaspo
et al., 1997) and clinical studies of AF (Konings et al., 1994).
Such findings suggest changes in gap junction conductance
do influence θ and arrhythmic susceptibility but only when the
majority of gap junctions are impaired. Instead, reductions in
membrane excitability and anatomical disruption are likely to
have greater roles in most pathologies.
FIBROSIS AND ITS RELATIONSHIP TO ra AND cm
Fibroblastsmake up 75% of the cells in themyocardium (Banerjee
et al., 2006). Indeed, sequential contraction of the atria and
ventricles is dependent on the annulus fibrosus cordis to elec-
trically insulate the two structures. In normal wound healing
they undergo apoptosis after having produced a mixture of cross-
linked collagen and other extracellular matrix (ECM) (Gurtner
et al., 2008).
However, in certain fibrotic conditions such as myocardial
infarction and cardiomyopathy, fibroblasts do not apoptose
and instead proliferate, migrate, and differentiate into myofi-
broblasts (Weber et al., 1994). Fibroblast and myofibroblasts
then continue to increase ECM deposition between layers of
neighboring cardiomyocytes unabated (Manabe et al., 2002).
This results in altered tissue architecture that in turn reduces
myocyte-myocyte coupling as well as results in the forma-
tion of fibroblast-myocyte couplings (Camelliti et al., 2004).
Such changes could in turn alter ra or cm, respectively slowing
conduction.
DISRUPTION OF CELL-TO CELL COUPLING AND ALTERATIONS IN ra
When healthy myocardium is disrupted by insulating connective
tissue, the current provided by cells preceding the disruption may
disperse along alternative branches, giving rise to a local conduc-
tion delay. Such current to load mismatches are found in fibrotic
myocardium (Spach et al., 1988; De Bakker et al., 1993) and have
been shown to impair conduction (Mendez et al., 1970; Spach
et al., 1982).
Experimental canine models of fibrosis have shown how the
deposition of insulating ECM and the decoupling of myocytes
[Figure 3C(i)] lead to the interruption of both longitudinal and
transverse cardiomyocyte-bundle continuity, producing zigzag
conduction patterns (Spach and Boineau, 1997; Burstein et al.,
2009). Such changes lead to conduction delays that predispose
to re-entry arrhythmias in both experimental (De Bakker et al.,
1993) and clinical studies (Spach, 2007).
COUPLING OF CARDIOMYOCYTES TO FIBROBLASTS AND
ALTERATIONS IN cm
Fibroblasts have been shown to electrically couple with car-
diomyocytes through Cx43 and Cx45 binding [Figure 3C(ii)]
(Camelliti et al., 2004; Chilton et al., 2007). Fibroblasts lack ion
channels associated with excitation. They also have depolarized
resting membrane potentials (Kamkin et al., 1999) and would
therefore modulate the membrane potential of the myocytes
to which they are coupled, potentially inactivating Na+ chan-
nels. In addition, the coupling of fibroblasts to myocytes pro-
duces a net increase in cell capacitance, cm (Miragoli et al.,
2006).
Both these features resulted in a slowing of conduction and
re-entrant events in cardiomyocytes co-cultured with fibroblasts
(Maleckar et al., 2009; Xie et al., 2009). The magnitude of these
effects on conduction appeared to be determined by the num-
ber of fibroblasts coupled to each cardiomyocyte, with significant
changes observed when 10–30 fibroblasts were coupled per car-
diomyocyte (Jacquemet and Henriquez, 2008; Maleckar et al.,
2009; Sachse et al., 2009).
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MURINE MODELS OF FIBROSIS
Experimental studies in mice have supported the association
between impaired conduction and fibrosis. However, most
murine models of fibrosis have concurrent pathological pro-
cesses that may additionally contribute to abnormal conduction,
making interpretation of their findings difficult. Thus, muta-
tions in sarcomere protein genes cause hypertrophic cardiomy-
opathy (HCM), a congenital condition associated with myocyte
enlargement and increased myocardial fibrosis, heart failure, and
arrhythmia (Lu et al., 2013). Experimental murine models that
carry mutations in the α- myosin heavy chain gene, MHC403,
show fibrosis, conduction abnormalities, and increased incidence
of inducible arrhythmia (Berul et al., 1998). Mutations in SCN5A
are associated with both BrS and Lenègre disease (Schott et al.,
1999). The latter condition produces progressive cardiac fibro-
sis and conduction abnormalities that lead to complete atri-
oventricular block and episodes of cardiac syncope. Scn5a+/−
hearts demonstrate similar age-related fibrosis and deteriora-
tion in conduction resembling the clinical phenotype of both
Lenègre’s disease (Lenegre and Moreau, 1963) and BrS (Coronel
et al., 2005). Finally, age-related upregulation of transforming
growth factor-β1 (TGF-β1) associated with increased measures
of fibrosis have been reported in Scn5a+/− hearts (Hao et al.,
2011).
TGF-β1 mediated myocardial fibrosis also directly plays
an important role in atrial arrhythmogenesis, including
AF (Nattel et al., 2005). Experimental studies suggest that
mice with increased expression of TGF-β1 have higher inci-
dences of AF and conduction abnormalities as a result
of raised levels of atrial fibrosis (Verheule et al., 2004).
Furthermore, atrial fibroblasts appear more sensitive to the
actions of TGF-β than their ventricular counterparts (Nakajima
et al., 2000). TGF-β1 polymorphisms are also thought to
be involved in inducing congenital heart block as a result
of fibrosis, leading to a predisposition to AF (Clancy et al.,
2003).
SUMMARY AND CONCLUSIONS
This review defines the determinants of θ as INa; ra and cm and
summarizes the mechanistic evidence that links changes in these
determinants with reduced myocardial θ and arrhythmogenesis.
Thus, firstly, (dV/dt)max is reduced by impaired Na+ chan-
nel function that arises clinically during heart failure, ischemia,
tachycardia, and following treatment with class I anti-arrhythmic
drugs. Such reductions also arise as a consequence of muta-
tions in SCN5A such as those in Lenègre disease, BrS, sick
sinus syndrome and AF. Secondly, ra may be increased due to
decreased gap junction coupling following ischemia, ventricu-
lar hypertrophy, and heart failure, or as a result of mutations
in CJA5 found in idiopathic AF and atrial standstill. Finally,
either ra or cm could potentially be altered by fibrotic change
through its effects upon decoupling myocyte-myocyte connec-
tions and through myocyte-fibroblast coupling. Such changes are
observed in myocardial infarction and cardiomyopathy or fol-
lowing mutations in MHC403 and SCN5A resulting in HCM or
Lenègre disease, respectively. The review thereby identifies the
diverse pathophysiological conditions in which abnormal θ may
contribute to arrhythmogenesis. Such findings provide insight
into the mechanisms of arrhythmogenesis in common arrhyth-
mias not usually attributed to impaired conduction such as those
associated with abnormal Ca2+ homeostasis.
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